Mesenchymal stem cells constitute a pool of cells present throughout the lifetime in
numerous niches, characteristic of unlimited replication potential and the ability to …

Aim The meta‐analysis of recent small animal experiments of mesenchymal stem/stromal
cells (MSC) therapy for impaired kidney could provide significant clues to design large …

Background. The immunoregulatory properties of mesenchymal stem cells (MSCs) have
been observed in vitro and in vivo. However, the underlying mechanisms of this …

Background The deleterious side effects of calcineurin inhibitors have impaired long-term
survival after renal allograft. New immunotherapy regimens that minimize or even eliminate …

Mesenchymal stromal cells (MSCs) exhibit anti-inflammatory and immune-regulatory
properties, and preclinical studies suggest a potential benefit in solid organ transplantation …

Kidney donation after circulatory death (DCD) is a less than ideal option to meet organ
shortages. Hypothermic machine perfusion (HMP) with Belzer solution (BS) improves the …

In solid organ transplantation, mesenchymal stem cell (MSC) therapy is strongly emerging
among other cell therapies due to the positive results obtained in vitro and in vivo as an …

Simple Summary In this study, we explore for the first time an innovative tool for organ
preservation aimed to preventing ischemia reperfusion injury (IRI) in marginal kidneys from …

This issue of Veterinary Clinics of North America: Small Animal Practice focuses on Chronic
Kidney Disease. Article topics include: New Biomarkers for Detecting Kidney Disease; Is …

Calcineurin inhibitors, including tacrolimus, are largely responsible for advances in
allotransplantation. However, the nephrotoxicity associated with these immunosuppressants …